Accumulation of molecular aberrations distinctive to hepatocellular carcinoma progression. Midorikawa Y, Yamamoto S, Tatsuno K, Renard-Guillet C, et al. Cancer Res 2020 Jul 8. pii: 0008-5472.CAN-20-0225.

Read + Share

Amedeo Smart

Independent Medical Education

Midorikawa Y, Yamamoto S, Tatsuno K, Renard-Guillet C, et al. Accumulation of molecular aberrations distinctive to hepatocellular carcinoma progression. Cancer Res 2020 Jul 8. pii: 0008-5472.CAN-20-0225.
PMID: 32641413